Aehr Test Systems (AEHR) just reported the largest order in its history, a US$41 million follow on production contract from a leading hyperscale AI customer for custom processor testing systems.

The record AI testing order comes after a sharp rerating in Aehr Test Systems’ shares, with a 30 day share price return of 135.03% and a 90 day gain of 262.99%, while the 1 year total shareholder return is very large, signalling strong positive momentum despite a recent 2.96% 7 day share price pullback.

If this kind of AI driven surge has your attention, it could be worth scanning other names riding similar themes with the 37 AI infrastructure stocks

With the stock now at US$93.07 and trading below the average analyst price target of US$63.67, investors are getting mixed signals. Is this AI testing specialist still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 409.4% Overvalued

At a last close of $93.07 versus a narrative fair value of $18.27, the most followed valuation story frames Aehr Test Systems as heavily priced in.

AEHR may still have attractive technology and exposure to semiconductor growth markets. But the capital allocation record deserves as much scrutiny as the product story.

For shareholders, the real story may not be burn-in systems or AI demand.

Want to see how this valuation view is built? The narrative leans heavily on aggressive revenue expansion, fragile profitability and a rich future earnings multiple. The exact mix of assumptions matters.

Result: Fair Value of $18.27 (OVERVALUED)

However, if insider selling slows or future orders materially support profitability, the market could reassess how stretched that 409.4% premium really is.

Next Steps

With sentiment clearly split between big AI potential and serious valuation questions, it makes sense to move quickly and test the data yourself using the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If you are serious about putting this AI story in context, the next smart step is comparing it with other focused stock ideas. Otherwise you risk missing opportunities hiding in plain sight.

• Target resilient companies that prioritize capital strength and consistent metrics by scanning the solid balance sheet and fundamentals stocks screener (46 results).
• Hunt for potential mispriced opportunities by checking the 52 high quality undervalued stocks that line up strong fundamentals with attractive entry points.
• Secure a steadier income stream by reviewing the 13 dividend fortresses built around higher yield payouts with an emphasis on durability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.